Back to search
FDAFDA · Food and drugs·Recall number Z-3047-2026

STA Staclot Protein S, Model/Catalog Number: 00746-Reagent Lot number 273074; qualitative and quantitative factor deficiency test

Published September 9, 2026 · Recall initiated: July 29, 2026

Summary

FDA records medical device Class II recall Z-3047-2026, published September 9, 2026 and initiated July 29, 2026. Recalling firm: Diagnostica Stago, Inc.; Status: Ongoing; Reported quantity: 5220 units; Lot: UDI : (01)3607450007466(11)250331(17)270331(10)273074(241)00746, Exp 3/31/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

A positive drift in QC values within the reagent's stated 4-hour onboard stability period was identified

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Diagnostica Stago, Inc.
Distributor
US Nationwide distribution in the states and territory of NJ, NY, NJ, VA, PA, FL, AL, GA, TN, OH, IL, MO, NE, TX, CO, UT, CA, PR.
Lot
UDI : (01)3607450007466(11)250331(17)270331(10)273074(241)00746, Exp 3/31/2027
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was STA Staclot Protein S, Model/Catalog Number: 00746-Reagent Lot number 273074; qualitative and quantitative factor deficiency test recalled?

Yes. FDA published recall Z-3047-2026 on September 9, 2026. Reported hazard: A positive drift in QC values within the reagent's stated 4-hour onboard stability period was identified

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail